Ypsomed plans over CHF 100 million expansion of autoinjector production at Solothurn

Ypsomed plans to invest more than CHF 100 million over the next four years to expand autoinjector production capacities at its Solothurn site, including doubling the capacity for injection moulding tool shop facilities.

“Over the next four years, Ypsomed plans to invest more than SFr100m to expand autoinjector production capacities at its Solothurn site.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comYpsomed to sell pen needle and BGMs businesses to MTDArchana RaniMar 28, 2024

Summarized from public sources; check the original articles before acting on it.